US Patent Issued to Angeles Therapeutics on April 8 for "Synthetic immune receptors and methods of use thereof" (California Inventor)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,859, issued on April 8, was assigned to Angeles Therapeutics Inc. (Toluca Lake, Calif.).

"Synthetic immune receptors and methods of use thereof" was invented by Preet M. Chaudhary (Toluca Lake, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides synthetic immune receptors (SIRs), nucleic acids encoding the SIRs, methods of making and using the SIRs, in, for example, adoptive cell therapy."

The patent was filed on Dec. 2, 2017, under Application No. 16/465,668.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...